From: Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
Characteristic | No of patients | Mean rank of CA125 | P value |
---|---|---|---|
Age | |||
≤50 | 253 | 530.87 | |
>50 | 742 | 486.79 | 0.04 |
Menopause | |||
No | 354 | 527.53 | |
Yes | 641 | 481.69 | 0.02 |
BMI (kg/m2) | |||
<25 | 501 | 517.25 | |
≥25 | 494 | 478.47 | 0.03 |
FIGO stage | |||
I | 769 | 425.27 | |
II | 85 | 642.04 | |
III | 116 | 785.00 | |
IV | 25 | 913.76 | 0.00 |
Histology type | |||
Endometrioid cancer | 955 | 495.08 | |
Non endometrioid cancer | 40 | 567.83 | 0.12 |
Histology grade | |||
1 | 495 | 447.52 | |
2 | 367 | 533.45 | |
3 | 133 | 588.06 | 0.00 |
Lymph node metastasis | |||
no | 895 | 466.82 | |
yes | 100 | 777.04 | 0.00 |
Adnexal involvement | |||
No | 931 | 473.39 | |
yes | 64 | 856.01 | 0.00 |
Distance metastasis | |||
no | 958 | 482.37 | |
yes | 37 | 885.90 | 0.00 |
myometrial invasion | |||
≤1/2 | 810 | 456.38 | |
>1/2 | 185 | 674.41 | 0.00 |
Cervical stromal invasion | |||
No | 859 | 460.02 | |
yes | 136 | 737.92 | 0.00 |
Positive peritoneal cytology | |||
No | 964 | 485.19 | |
yes | 31 | 909.97 | 0.00 |